+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Key Trials of the Decade, An Issue of Interventional Cardiology Clinics. The Clinics: Internal Medicine Volume 9-4

  • Book
  • September 2020
  • Elsevier Health Science
  • ID: 5230706

This issue of Interventional Cardiology Clinics, guest edited by Editor-in-Chief Matthew J. Price, will focus on Key Trials of the Decade. Trials discussed in this issue will include: Physiology over Angiography to determine lesion severity: The FAME trials; Percutaneous Coronary Intervention or surgery for multivessel disease: The SYNTAX trial at 10 years; Percutaneous Coronary Intervention or surgery for unprotected left main disease: The EXCEL trial at 5 years; Complete or Incomplete Revascularization for ST-Elevation Myocardial Infarction: the PRAMI trial and beyond; Abbreviated Dual Antiplatelet Therapy after PCI in High Bleeding Risk Patients: LEADERS-FREE and ONYX ONE; Transcatheter treatment of functional mitral regurgitation in patients with heart failure: The COAPT trial; Manual thrombectomy in Primary Percutaneous Coronary Intervention: Lessons learned from TOTAL; Paradigm shifts in the treatment of aortic stenosis: The PARTNER Trials experience; COURAGE and ORBITA in context: PCI for chronic stable CAD; SIMPLICITY to RADIANCE: Interpreting the past and mapping the future of renal denervation; From WOEST to AUGUSTUS: Dual Therapy after PCI; The ISCHEMIA Trial: Background, Design, Outcomes and Clinical Interpretation.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Authors

Matthew J. Price Director, Cardiac Catheterization Laboratory, Scripps Green Hospital; Division of Cardiovascular Diseases, Scripps Clinic; Assistant Professor, Scripps Translational Science Institute, La Jolla, California. Matthew Price, MD, a new editor joining the revision, is Director of the Cardiac Catheterization Laboratory at Scripps Clinic